PAX2 and renal cell carcinoma: During epithelial-to-mesenchyme (EMT) transition of RCC cells, silencing of PAX2 expression reduces ADAM10 expression, which induces L1-CAM-dependent activation of the PI3K/Akt pathway, which is crucial for RCC cell survival [40].